Current status and recent advances in reirradiation of glioblastoma

Bibliographic Details
Title: Current status and recent advances in reirradiation of glioblastoma
Authors: Giuseppe Minniti, Maximilian Niyazi, Filippo Alongi, Piera Navarria, Claus Belka
Source: Radiation Oncology, Vol 16, Iss 1, Pp 1-14 (2021)
Publisher Information: BMC, 2021.
Publication Year: 2021
Collection: LCC:Medical physics. Medical radiology. Nuclear medicine
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Target delineation, Recurrent glioblastoma, Reirradiation, Stereotactic radiosurgery, Hypofractionated radiotherapy, Radionecrosis, Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Despite aggressive management consisting of maximal safe surgical resection followed by external beam radiation therapy (60 Gy/30 fractions) with concomitant and adjuvant temozolomide, approximately 90% of WHO grade IV gliomas (glioblastomas, GBM) will recur locally within 2 years. For patients with recurrent GBM, no standard of care exists. Thanks to the continuous improvement in radiation science and technology, reirradiation has emerged as feasible approach for patients with brain tumors. Using stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT), either hypofractionated or conventionally fractionated schedules, several studies have suggested survival benefits following reirradiation of patients with recurrent GBM; however, there are still questions to be answered about the efficacy and toxicity associated with a second course of radiation. We provide a clinical overview on current status and recent advances in reirradiation of GBM, addressing relevant clinical questions such as the appropriate patient selection and radiation technique, optimal dose fractionation, reirradiation tolerance of the brain and the risk of radiation necrosis.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1748-717X
Relation: https://doaj.org/toc/1748-717X
DOI: 10.1186/s13014-021-01767-9
Access URL: https://doaj.org/article/68810263557b47feb022513c26beefd8
Accession Number: edsdoj.68810263557b47feb022513c26beefd8
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:1748717X
DOI:10.1186/s13014-021-01767-9
Published in:Radiation Oncology
Language:English